Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies

Anti-tumour T cell responses play a crucial role in controlling the progression of colorectal cancer (CRC), making this disease a promising candidate for immunotherapy. However, responses to immune-targeted therapies are currently limited to subpopulations of patients and specific types of cancer. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Nicholas J., Peyroux, Estelle M., Ferguson, Angela L., Steain, Megan, Neumann, Silke, Young, Sarah L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160415/
https://www.ncbi.nlm.nih.gov/pubmed/37153625
http://dx.doi.org/10.3389/fimmu.2023.1152035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160415/
https://www.ncbi.nlm.nih.gov/pubmed/37153625
http://dx.doi.org/10.3389/fimmu.2023.1152035

Ejemplares similares